Literature DB >> 29387462

Dilemmas in the Dosing of Heart Failure Drugs: Titrating Diuretics in Chronic Heart Failure.

David Pham1, Justin L Grodin1.   

Abstract

Despite advances in medical therapy over the past few decades, the incidence of heart failure hospitalisation continues to rise. Diuretics are the most common therapy used to treat heart failure as they relieve congestion. However, there is a lack of guidance on how to best use these medications. Guidelines support the use of diuretics at the lowest clinically effective dose but do not specify a diuretic strategy beyond that. Here we review the diuretics available for treatment, potential mechanisms of diuretic resistance and ways to address this in the ambulatory setting, and review tools that have been developed to help guide diuretic use in the treatment of chronic heart failure.

Entities:  

Keywords:  Loop diuretic; bumetanide; diuretic resistance; furosemide; heart failure; torsemide

Year:  2017        PMID: 29387462      PMCID: PMC5789220          DOI: 10.15420/cfr.2017:10:1

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN: 2057-7540


  63 in total

1.  Subcutaneous furosemide.

Authors:  Miguel A Goenaga; Manuel Millet; Eloy Sánchez; Carmen Garde; José A Carrera; Edurne Arzellus
Journal:  Ann Pharmacother       Date:  2004-08-31       Impact factor: 3.154

2.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

3.  Diuretic response in acute heart failure-an analysis from ASCEND-HF.

Authors:  Jozine M ter Maaten; Allison M Dunning; Mattia A E Valente; Kevin Damman; Justin A Ezekowitz; Robert M Califf; Randall C Starling; Peter van der Meer; Christopher M O'Connor; Phillip J Schulte; Jeffrey M Testani; Adrian F Hernandez; W H Wilson Tang; Adriaan A Voors
Journal:  Am Heart J       Date:  2015-05-09       Impact factor: 4.749

4.  Reduced bioavailability and effect of furosemide given with food.

Authors:  B Beermann; C Midskov
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Clinical trial of bumetanide versus furosemide in patients with congestive heart failure.

Authors:  L L Konecke
Journal:  J Clin Pharmacol       Date:  1981 Nov-Dec       Impact factor: 3.126

6.  Diuretic response in acute heart failure: clinical characteristics and prognostic significance.

Authors:  Mattia A E Valente; Adriaan A Voors; Kevin Damman; Dirk J Van Veldhuisen; Barrie M Massie; Christopher M O'Connor; Marco Metra; Piotr Ponikowski; John R Teerlink; Gad Cotter; Beth Davison; John G F Cleland; Michael M Givertz; Daniel M Bloomfield; Mona Fiuzat; Howard C Dittrich; Hans L Hillege
Journal:  Eur Heart J       Date:  2014-02-28       Impact factor: 29.983

7.  Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.

Authors:  J Hensen; W T Abraham; J A Dürr; R W Schrier
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

8.  Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.

Authors:  Leo F Buckley; Danielle M Carter; Lina Matta; Judy W Cheng; Craig Stevens; Roman M Belenkiy; Laura J Burpee; Michelle A Young; Cynthia S Weiffenbach; Jennifer A Smallwood; Lynne W Stevenson; Akshay S Desai
Journal:  JACC Heart Fail       Date:  2015-12-02       Impact factor: 12.035

9.  Comparison of loop diuretics in patients with chronic renal insufficiency.

Authors:  J R Voelker; D Cartwright-Brown; S Anderson; J Leinfelder; D A Sica; J P Kokko; D C Brater
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

10.  Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.

Authors:  A A van Vliet; A J Donker; J J Nauta; F W Verheugt
Journal:  Am J Cardiol       Date:  1993-01-21       Impact factor: 2.778

View more
  3 in total

1.  Identifying Adverse Drug Events in Older Community-Dwelling Patients.

Authors:  Caitriona Cahir; Emma Wallace; Anthony Cummins; Conor Teljeur; Catherine Byrne; Kathleen Bennett; Tom Fahey
Journal:  Ann Fam Med       Date:  2019-03       Impact factor: 5.166

2.  A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics.

Authors:  Ertan Yetkin; Bilal Cuglan; Hasan Turhan; Selcuk Ozturk
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-15

3.  Renal function, electrolytes, and congestion monitoring in heart failure.

Authors:  Patrick Rossignol; Andrew Js Coats; Ovidiu Chioncel; Ilaria Spoletini; Giuseppe Rosano
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.